Alfred Guirguis, DO
Gynecologic Oncology · Oak Lawn, ILNPI 1063539211
Payments from drug & device makers
Across 243 payments — averaging $353.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$45K
- Baxter Healthcare$17K
- AstraZeneca$15K
- Karyopharm Therapeutics Inc.$3K
- Novartis$1K
- Intuitive Surgical$918
- plus $3K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 17 | $44,799 |
| Baxter Healthcare | 18 | $17,377 |
| AstraZeneca | 38 | $15,194 |
| Karyopharm Therapeutics Inc. | 8 | $2,967 |
| Novartis | 6 | $1,262 |
| Intuitive Surgical | 7 | $918 |
| Merck | 40 | $876 |
| Eisai Inc. | 21 | $408 |
| GSK | 12 | $323 |
| Amgen | 10 | $221 |
| Clovis Oncology, Inc. | 12 | $209 |
| Amneal Pharmaceuticals LLC | 7 | $185 |
| Pfizer | 6 | $120 |
| AbbVie | 5 | $114 |
| On Target Laboratories, Inc | 1 | $97 |
| Astellas Pharma US Inc | 4 | $91 |
| Genentech USA, Inc. | 4 | $85 |
| Tempus AI, Inc | 3 | $81 |
| Foundation Medicine, Inc. | 4 | $74 |
| Myriad Genetic Laboratories, Inc. | 3 | $67 |
| Abbott | 1 | $62 |
| Aspira Women's Health Inc | 3 | $51 |
| Medtronic | 1 | $47 |
| Menarini Silicon Biosystems, Inc. | 1 | $38 |
| Tactile Systems Technology Inc | 1 | $32 |
| Coherus Oncology, Inc. | 1 | $31 |
| Johnson & Johnson | 1 | $31 |
| Caris MPI, Inc. | 1 | $27 |
| Celltrion USA Inc. | 1 | $27 |
| Incyte Corporation | 1 | $23 |
| Tesaro, Inc. | 1 | $23 |
| Spectrum Pharmaceuticals Inc. | 1 | $22 |
| Immunogen, Inc. | 1 | $19 |
| Dysis Medical, Inc. | 1 | $13 |
| Duchesnay USA Incorporated | 1 | $12 |
How this compares
$85,928 in reported general payments places this provider in the 75th percentile of 64 gynecologic oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in Oak Lawn
- Nikki NeubauerOak Lawn$260K
- Michael LoweOak Lawn$9K
- Carrie McIlwainOak Lawn$1K
- John MoroneyChicago$3.3M
- Sudarshan SharmaHinsdale$2.6M
- Dario RoqueChicago$1.2M
- Amina AhmedChicago$1.1M
- Emma BarberChicago$897K
- Julian SchinkChicago$388K
- Jenna MarcusChicago$381K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.